Non-operative management of cirrhotic patients with acute calculous cholecystitis: How effective is it?

Kamil Hanna,Bardiya Zangbar,Jordan Kirsch,Matthew Bronstein,Kenji Okumura,Shekhar Gogna,Ilya Shnaydman,Kartik Prabhakaran,Jorge Con
DOI: https://doi.org/10.1016/j.amjsurg.2023.07.019
2023-07-13
Abstract:Introduction Nonoperative management (NOM) of acute calculous cholecystitis (ACC) in patients with cirrhosis was proposed. We examined the outcomes of cirrhotic patients with ACC treated with cholecystectomy compared to NOM. Methods We analyzed the 2017-Nationwide Readmissions Database including cirrhotic patients with ACC. Patients were stratified: cholecystectomy, percutaneous cholecystostomy (PCT), and antibiotics only. Primary outcomes: complications, failure of NOM. Secondary outcomes: mortality, length of stay (LOS), and charges. Results 3454 patients were identified. 1832 underwent cholecystectomy, 360 PCT, and 1262 were treated with antibiotics. PCT patients had higher mortality 16.9% vs. the antibiotics group 10.9% vs. cholecystectomy group 4.2%. PCT patients had longer LOS, but lower charges compared to the operative group. Failure of NOM was 28.2%. On regression, PCT was associated with mortality. Conclusion ACC remains a morbid disease in cirrhosis patients. One in three failed NOM, had longer LOS, and higher mortality. Further studies are warranted to identify predictors of NOM failure. Level of evidence Level III, prognostic.
surgery
What problem does this paper attempt to address?